Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march
- PMID: 28583445
- DOI: 10.1016/j.jaci.2017.04.004
Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march
Abstract
Skin barrier abnormalities have been suggested to play an essential role in initiation of early atopic dermatitis (AD). Antigen penetration through a compromised barrier likely leads to increased innate immune responses, antigen-presenting cell stimulation, and priming of overt cutaneous disease. In a TH2-promoting environment, T-cell/B-cell interactions occurring in regional lymph nodes lead to excessive IgE switch. Concurrent redistribution of memory T cells into the circulation not only leads to exacerbation of AD through T-cell skin infiltration but also spreads beyond the skin to initiate the atopic march, which includes food allergy, asthma, and allergic rhinitis. Possible primary interventions to prevent AD are focusing on improving skin barrier integrity, including supplementing barrier function with moisturizers. As for secondary prophylaxis in children with established AD, this can be stratified into prevention of disease exacerbations by using proactive approaches (with either topical corticosteroids or topical calcineurin inhibitors) in mild AD cases or the prevention of other atopic disorders that will probably mandate systemic immunosuppression in severe AD cases.
Keywords: Atopic dermatitis; atopic march; epidermal barrier; immune dysregulation; microbiome; primary intervention; secondary intervention.
Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Epithelial barrier dysfunctions in atopic dermatitis: a skin-gut-lung model linking microbiome alteration and immune dysregulation.Br J Dermatol. 2018 Sep;179(3):570-581. doi: 10.1111/bjd.16734. Epub 2018 Jul 11. Br J Dermatol. 2018. PMID: 29761483 Review.
-
The ins and outs of an 'outside-in' view of allergies: atopic dermatitis and allergy prevention.Curr Opin Pediatr. 2018 Aug;30(4):576-581. doi: 10.1097/MOP.0000000000000646. Curr Opin Pediatr. 2018. PMID: 29750772 Review.
-
The atopic march and atopic multimorbidity: Many trajectories, many pathways.J Allergy Clin Immunol. 2019 Jan;143(1):46-55. doi: 10.1016/j.jaci.2018.11.006. Epub 2018 Nov 17. J Allergy Clin Immunol. 2019. PMID: 30458183 Review.
-
Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.J Allergy Clin Immunol Pract. 2014 Jul-Aug;2(4):371-9; quiz 380-1. doi: 10.1016/j.jaip.2014.03.006. Epub 2014 Apr 25. J Allergy Clin Immunol Pract. 2014. PMID: 25017523 Review.
-
The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells?Trends Immunol. 2007 Jul;28(7):294-8. doi: 10.1016/j.it.2007.05.003. Epub 2007 Jun 4. Trends Immunol. 2007. PMID: 17544846
Cited by
-
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?Nat Rev Immunol. 2021 Nov;21(11):739-751. doi: 10.1038/s41577-021-00538-7. Epub 2021 Apr 12. Nat Rev Immunol. 2021. PMID: 33846604 Review.
-
More from the Pipeline of Clinical Research on SELECTED SYSTEMIC THERAPIES FOR ATOPIC DERMATITIS.J Clin Aesthet Dermatol. 2019 May;12(5):49-53. Epub 2019 May 1. J Clin Aesthet Dermatol. 2019. PMID: 31320978 Free PMC article.
-
Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro.Br J Pharmacol. 2018 Dec;175(23):4310-4324. doi: 10.1111/bph.14487. Epub 2018 Nov 6. Br J Pharmacol. 2018. PMID: 30187459 Free PMC article.
-
Time Trends in the Prevalence of Atopic Dermatitis in Korean Children According to Age.Allergy Asthma Immunol Res. 2022 Jan;14(1):123-130. doi: 10.4168/aair.2022.14.1.123. Allergy Asthma Immunol Res. 2022. PMID: 34983112 Free PMC article.
-
Biological drugs in the treatment of atopic dermatitis - current recommendations of the Polish Dermatological Society, the Polish Society of Allergology, the Polish Pediatric Society and the Polish Society of Family Medicine.Postepy Dermatol Alergol. 2020 Oct;37(5):617-624. doi: 10.5114/ada.2020.100496. Epub 2020 Nov 7. Postepy Dermatol Alergol. 2020. PMID: 33239998 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials